Abstract P209 Table 1

Association between clinical and demographic features of cohort and death at 30 days

Demographic featureNumber of individuals (n = 790) (%)Number of deaths at 30 days (n = 240) (%)Crude OR
(95% CI)
Adjusted OR (95% CI)*
SexFemale394 (49.9)111 (46.2)1.001.00
Male396 (50.1)129 (53.8)1.23 (0.91–1.67)1.38 (0.96–1.99)
Age category (years)<70184 (23.3)27 (11.3)1.001.00
70–79182 (23.0)58 (24.2)2.72 (1.63–4.55)2.30 (1.28–4.14)
80–89305 (38.6)113 (47.1)3.42 (2,14–5.48)3.18 (1.86–5.43)
≥90119 (15.1)42 (17.5)3.17 (1.82–5.52)3.23 (1.71–6.10)
Admitted from nursing homeNo734 (92.9)218 (90.8)1.001.00
Yes56 (7.1)22 (9.2)1.54 (0.88–2.68)1.47 (0.75–2.91)
Charlson Index Score0186 (23.5)29 (12.1)1.001.00
1178 (22.5)49 (20.4)2.06 (1.23–3.44)1.94 (1.09–3.44)
2–3248 (31.4)79 (32.9)2.53 (1.57–4.08)2.15 (1.27–3.66)
≥4178 (22.5)83 (34.6)4.73 (2.89–7.74)4.34 (2.50–7.53)
Consolidation on CXRNo138 (17.5)35 (14.6)1.001.00
Yes386 (48.9)132 (55.0)1.53 (0.98–2.37)1.48 (0.92–2.39)
Timing of HAP antibioticsAdmission or ≤48 h of admission192 (24.3)59 (24.6)1.001.00
2–4 days from admission169 (21.4)42 (17.5)0.75 (0.47–1.19)0.81 (0.48–1.39)
≥5 days from admission429 (54.3)139 (57.9)1.08 (0.75–1.56)0.87 (0.57–1.33)
White cell count (quintiles)≤7.9191 (24.2)47 (20.0)1.001.00
8.0–10.9189 (23.9)53 (22.1)1.19 (0.76–1.89)1.01 (0.59–1.67)
11.0–14.6190 (24.1)61 (25.4)1.45 (0.93–2.27)1.20 (0.72–2.02)
≥14.7190 (24.1)69 (28.8)1.74 (1.12–2.72)1.38 (0.83–2.31)
Missing30 (3.8)---
C Reactive Protein (quintiles)≤45187 (23.7)41 (17.1)1.001.00
46–87186 (23.5)60 (25.0)1.70 (1.06–2.69)1.90 (1.12–3.22)
88–174187 (23.7)73 (30.4)2.28 (1.45–3.59)2.42 (1.42–4.12)
≥175185 (23.4)55 (22.9)1.51 (0.94–2.41)1.56 (0.90–2.70)
Missing45 (5.7)---
  • *Odds ratio adjusted for all variables in table.